MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/10760296261438236

Медицинская библиотека · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 2026

Diagnostic Value of Coagulation-Fibrinolysis Biomarkers for Metastasis in Lung, Ovarian, Breast, and Colorectal Cancers.

Zhao Yumei, Sun Xinping, Lin Bozhi, Xu Shiyuan, Gao Huafang

СтатьяПеревод в очереди

Аннотация

IntroductionDysregulation of the coagulation and fibrinolytic systems has been closely linked to cancer progression and metastasis. This study investigated whether the coagulation- and fibrinolysis-related biomarkers, TAT, PIC, TM, and tPAIC, are correlated with cancer metastasis.MethodsPlasma levels of TAT, PIC, TM, and tPAIC were measured in 240 treatment-naive patients with lung, ovarian, breast, or colorectal cancer and 120 healthy individuals. Participants were categorized into metastasis, non-metastasis and healthy groups based on clinical evaluation and imaging results. Statistical analysis and ROC curves were used to assess the performance of individual and combined biomarkers in detecting metastasis.ResultsAll four biomarkers were significantly elevated in patients with metastasis (P < .001). In multivariate logistic regression analysis, PIC demonstrated the strongest association with metastasis. ROC curve analysis revealed that in lung cancer patients, a parallel test of TAT and PIC achieved a sensitivity of 93.33% and an NPV of 88.24%. In ovarian cancer, a serial test of TAT, PIC, and TM achieved a specificity of 80.00% and a PPV of 75.00%. In breast cancer, a parallel test of TAT, PIC, and tPAIC yielded a sensitivity of 93.33% and an NPV of 89.47%. In colorectal cancer, a parallel test of all four markers achieved a sensitivity of 96.67% and an NPV of 93.75%.ConclusionDistinct combinations of coagulation and fibrinolysis biomarkers demonstrate high diagnostic performance for detecting metastasis across different cancer types. Tailoring biomarker panels according to cancer type may provide significant clinical value in monitoring and predicting cancer metastasis.

Для цитирования: Zhao Yumei, Sun Xinping, Lin Bozhi, Xu Shiyuan, Gao Huafang. Diagnostic Value of Coagulation-Fibrinolysis Biomarkers for Metastasis in Lung, Ovarian, Breast, and Colorectal Cancers.. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2026. DOI: 10.1177/10760296261438236.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.